Insight
Raymond Chan, Morning Fatigue
Raymond Chan/X

Raymond Chan: Great to see the EMINENT trial in print

Raymond Chan, Deputy Vice-Chancellor (Research) at Flinders University, shared eClinicalMedicine – The Lancet Discovery Science’s post on LinkedIn:

“Great to see the EMINENT trial in print. We are now writing up IBIS and hope we share the findings as soon as we can!”

Quoting eClinicalMedicine – The Lancet Discovery Science’s post on LinkedIn about a recent paper shared by Raymond Chan et al. published in eClinicalMedicine:

“In our Current Issue

Available at a screen near you! All open access !!!

The EMINENT Trial

Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in early breast cancer post-treatment follow-up (EMINENT): a single-centre, open-label, phase 2, parallel-group, pilot, randomised, controlled trial

Raymond Chan, Fiona Crawford-Williams, Chad Han and team at Flinders Health and Medical Research Institute, Flinders University aimed to evaluate the feasibility and preliminary effectiveness of implementing nurse-enabled, shared-follow-up care between the acute and primary care setting for early-stage breast cancer.

Read their findings.”

Authors: Raymond Chan et al.

Raymond Chan

Alexandre Chan Bethany Crowe Breast Cancer cancer Carolyn Ee Chad Han Chad Yixian Han Christine Carrington Daniel McKavanagh Emma McKinnell Fiona Crawford-Williams Flinders Health and Medical Research Institute Jane Lee Jon Emery Juanita Ryan Katharine Cuff Laisa Teleni Lee Jones Marissa Ryan Megan Crichton Melissa Gosper Nicolas H. Hart. OncoDaily Oncology Raymond Chan Rebecca L. Packer Ria Joseph Steven M. McPhail